- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech High Growth Potential Companies
Taiwanese Pharmaceuticals & Biotech High Growth Potential Companies
Results
6
Companies with a Future performance score of at least 3, ordered by Future performance score.
6 companies
PharmaEssentia
Market Cap: NT$191.9b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$519.00
7D
6.8%
1Y
-9.3%
Lotus Pharmaceutical
Market Cap: NT$61.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$232.00
7D
21.1%
1Y
-13.3%
Caliway Biopharmaceuticals
Market Cap: NT$291.6b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$188.00
7D
-4.1%
1Y
213.3%
ScinoPharm Taiwan
Market Cap: NT$15.2b
Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.
1789
NT$19.25
7D
1.9%
1Y
-23.8%
Bora Pharmaceuticals
Market Cap: NT$84.2b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$678.00
7D
-3.0%
1Y
8.5%
Ever Supreme Bio Technology
Market Cap: NT$15.6b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$178.50
7D
8.5%
1Y
7.0%